Stock Price Quote

ZENITH HEALTH CARE LTD.

NSE : NABSE : 530665ISIN CODE : INE812B01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.470.02 (+0.45 %)
PREV CLOSE ( ) 4.45
OPEN PRICE ( ) 4.52
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25155
TODAY'S LOW / HIGH ( )4.35 4.52
52 WK LOW / HIGH ( ) 3.616.5
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-11 1994
Management Info
Mahendra C Raycha - Chairman Mahendra C Raycha - Managing Director
Registered Office

Address 504, Iscon Elegance,Near Ananddham Jain Derasar,Prahladnagar Cross Road, S G Road,
Ahmedabad,
Gujarat-380015

Phone 079 66168889 / 90 / 40095550

Email mahendrazenith@hotmail.com

Website www.zenithhealthcare.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, Ahmedabad

NEWS

12Oct Zenith Health Care informs about confi
Zenith Health Care has informed about confirmation certificate received..
16Apr Zenith Healthcare informs about non-ap
Zenith Healthcare has informed that the Provisions contained in SEBI Cir..
08Apr Zenith Healthcare informs about certif
Zenith Healthcare has informed that it enclosed a Certificate/ Declarati..
29Sep Zenith Healthcare informs about re-app
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
10Oct Zenith HealthCare planning to amalgama
Zenith HealthCare is planning for amalgamation of Zenith Medicine with i..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit1.000000000000010.790000000000031
Gross Profit 1.00000000000001 1.19000000000003
Operating Profit 1.570000000000014.06000000000003
Net Sales 38.92131.29

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  7519.90 (5.84%)
M.Cap ( in Cr)9647.95
NGL Fine-Chem (BSE)
peergroup  2264.35 (5.97%)
M.Cap ( in Cr)1398.92
Astrazeneca Pharma I (BSE)
peergroup  5288.60 (1.85%)
M.Cap ( in Cr)13221.50
Divi's Lab (BSE)
peergroup  3764.65 (1.32%)
M.Cap ( in Cr)99939.63
Dr. Reddy's Lab (BSE)
peergroup  6052.00 (0.70%)
M.Cap ( in Cr)100958.41

Shareholding Pattern

NON-INSTITUTION 70.87%
PROMOTERS 28.74%
MUTUAL FUNDS/UTI 0.39%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Zenith Health Care Ltd.

Zenith Health Care Ltd. was incorporated in the year 1994. Its today's share price is 4.47. Its current market capitalisation stands at Rs 24.02 Cr. In the latest quarter, company has reported Gross Sales of Rs. 131.31 Cr and Total Income of Rs.135.05 Cr. The company's management includes Mihir Satishkumar Shah, Rajesh Thakker, Tejas Thakker, Gaurang Vora, Atul Thakker, Neela Raycha, Akshit Raycha, Mahendra C Raycha, Mahendra C Raycha.

It is listed on the BSE with a BSE Code of 530665 , NSE with an NSE Symbol of and ISIN of INE812B01026. It's Registered office is at 504, Iscon Elegance,Near Ananddham Jain Derasar,Prahladnagar Cross Road, S G RoadAhmedabad-380015, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are A R Pandhi & Associates, Jayesh R Mor & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.